lapatinib has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Khatib, AS; Fawzy, HM; Khattab, MM; Mansour, HM | 2 |
2 other study(ies) available for lapatinib and Alzheimer Disease
| Article | Year |
|---|---|
Inhibition of mitochondrial pyruvate carrier 1 by lapatinib ditosylate mitigates Alzheimer's-like disease in D-galactose/ovariectomized rats.
Topics: Alzheimer Disease; Animals; Female; Galactose; Lapatinib; Maze Learning; Mitochondrial Proteins; Monocarboxylic Acid Transporters; Ovariectomy; Protein Kinase Inhibitors; Rats; Rats, Wistar; Solute Carrier Proteins | 2021 |
Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Repositioning; Female; Galactose; Hippocampus; Lapatinib; Maze Learning; Memory Disorders; Ovariectomy; Peptide Fragments; Rats; Rats, Wistar; Treatment Outcome | 2021 |